Better Therapeutics

Digital health firm Better Therapeutics makes Nasdaq debut

Better Therapeutics has joined the ranks of publicly-listed digital health companies after completing a merger with blank cheque company Mountain Crest Acquisition Corp II. The company, which specialises in prescription digital therapeutics (DTx) for cardiometabolic diseases, listed on the Nasdaq under the BTTX ticker late on Friday. Shares initially fell back slightly from an opening …

Digital health firm Better Therapeutics makes Nasdaq debut Read More »

Better Therapeutics begins ‘real world’ study of digital diabetes therapy

After announcing plans to go public, prescription digital therapeutics (DTx) firm Better Therapeutics has begun a “real world” study to test whether its BT-001 prescription cognitive behavioural therapy tool could change behaviours that are the root cause of type 2 diabetes. The company has begun the open-label, non-randomised, controlled study to test whether the durability …

Better Therapeutics begins ‘real world’ study of digital diabetes therapy Read More »